Haleon
HLN
9.07
+0.02
+0.22%
Haleon
US · HLN
#553 by market cap
Listed 2022
9.07
+0.02
+0.22%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:59
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 15 in the most recent period (2026/Q4).
- Total institutional ownership fell 0.1 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 95.33% -0.15pp
- Institutions
- 1,071 -15
- As of
- 2026/Q4 vs. prior period
Holder types
Mutual Fund81.48%
Private Company3.80%
Sovereign Wealth Fund3.78%
Public Company2.57%
Government Pension Fund1.51%
Hedge Fund1.28%
VC/PE Fund0.43%
Government0.16%
Insurance Company0.15%
Other4.83%
Top holders as of 2026-09-30
BlackRock
8.76% · 385.24M sh
Dodge & Cox
5.76% · 253.38M sh
MFS Investment Management
4.06% · 178.53M sh
Vanguard Capital Management, LLC
3.93% · 172.96M sh
First Eagle Investment Management, LLC
2.71% · 119.12M sh
Schroder Investment Management Limited
2.46% · 108.27M sh
Wellington Management Group
2.19% · 96.43M sh
Principal Global Investors, LLC
2.03% · 89.28M sh
Amundi Asset Management
1.90% · 83.50M sh
Norges Bank Investment Management
1.87% · 82.16M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
2 filings tracked · 0 buys · 2 sells
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2023-12-26 | Glaxosmithkline (Us) Trust | -- | Intent to Sell (Form 144) | -8,527,104 | $8.28 |
| 2023-12-04 | Gsk Master Grantor Trust | -- | Intent to Sell (Form 144) | -404,599 | $8.57 |
| 2023-11-05 | GlaxoSmithKline Employee Trust | -- | Intent to Sell (Form 144) | -173,611 | $7.96 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:59:23 · For reference only, not investment advice and not tailored to your situation.
Haleon discussion 0 comments